
Smith & Nephew plc SNN
$ 33.0
0.49%
Annual report 2024
added 12-06-2025
Smith & Nephew plc Interest Expense 2011-2025 | SNN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Smith & Nephew plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 M | 132 M | 80 M | 80 M | 62 M | 65 M | 59 M | 57 M | 52 M | 49 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 145 M | 49 M | 78.1 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.51 | -2.5 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 95.92 | -0.19 % | $ 141 B | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.45 | -0.94 % | $ 678 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 302.98 | 0.26 % | $ 8.55 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 48.08 | -0.09 % | $ 7.16 K | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.99 | 0.11 % | $ 217 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.13 | 5.29 % | $ 117 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 157.74 | -0.06 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.84 | -2.02 % | $ 86.3 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.97 | -0.09 % | $ 1.23 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 14.01 | -3.31 % | $ 379 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.51 | -0.17 % | $ 95.1 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.58 | -0.2 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.08 | 0.1 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.96 | -0.19 % | $ 3.41 B | ||
|
LENSAR
LNSR
|
660 K | $ 12.04 | 0.27 % | $ 139 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.37 | -0.23 % | $ 401 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 88.04 | -0.54 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.67 | 0.04 % | $ 976 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.48 | -0.6 % | $ 3.87 M | ||
|
PAVmed
PAVM
|
-10.5 M | $ 0.28 | 0.5 % | $ 2.02 M |